Marsh & McLennan Companies, Inc. (MRSH)
Marsh Strengthens Advisory Business With TriBridge Acquisition
MRSH unit Marsh McLennan Agency expands its advisory footprint with TriBridge, adding retirement, wealth and benefits expertise.
Marsh & McLennan: 16 Years Of Dividend Growth And Counting
Marsh & McLennan is delivering robust organic revenue growth, strong EPS beats and maintains a compelling dividend profile amid sector headwinds. MRSH trades at a forward P/E of 14.9, well below its 10-year average of 21.9, presenting a 26% discount to fair value. With an A- S&P rating, MRSH is positioned for continued bolt-on acquisitions and sustained dividend growth, targeting at least 9% annual increases.
Marsh & McLennan Companies, Inc. (MRSH) Q1 2026 Earnings Call Transcript
Marsh & McLennan Companies, Inc. (MRSH) Q1 2026 Earnings Call Transcript
Marsh (MRSH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Marsh (MRSH) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Marsh (MRSH) Beats Q1 Earnings and Revenue Estimates
Marsh (MRSH) came out with quarterly earnings of $3.29 per share, beating the Zacks Consensus Estimate of $3.21 per share. This compares to earnings of $3.06 per share a year ago.
Can Marsh Navigate Through Rising Costs in Q1 Earnings?
MRSH is set to report Q1 2026 earnings on April 16, with EPS expected to rise 4.9% and revenues 4.6%. But rising operating costs could cloud results.
Marsh (MRSH) Earnings Expected to Grow: Should You Buy?
Marsh (MRSH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Marsh (MRSH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Investors Should Retain Marsh & McLennan Stock for Now
MRSH shows steady growth backed by acquisitions, AI-driven strategy and strong cash flow, but rising costs and debt levels may temper upside potential.
Marsh & McLennan Remains An Attractive Growth Play In The Insurance Sector
Marsh & McLennan Companies, Inc. remains a compelling growth play in insurance, with strong fundamentals and a strategy blending organic initiatives and targeted acquisitions. Recent headwinds—AI disruption fears, cyclical pricing pressure, and higher leverage post-McGriff—have driven MRSH stock underperformance and compressed valuation to 18.4x forward earnings. Despite increased net debt (2.6x EBITDA), MRSH's robust $5B free cash flow supports ongoing debt reduction, capital returns, and selective bolt-on M&A.
Marsh Strengthens Private Markets Push With AltamarCAM Buy
MRSH to expand private markets' reach as Mercer agrees to acquire AltamarCAM, boosting alternative investment capabilities and global platform strength.
Marsh (MRSH) Surges 3.3%: Is This an Indication of Further Gains?
Marsh (MRSH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
